Gail Cawkwell - 12 Aug 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
SVP, Med Affairs, Safety & PV
Signature
/s/ Mary J. Grendell, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
12 Aug 2021
Net transactions value
-$4,874
Form type
4
Filing time
13 Aug 2021, 19:01:26 UTC
Previous filing
13 May 2021
Next filing
16 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $4,874 -319 -0.98% $15.28 32,234 12 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.